ArticleJournal of medicinal chemistry2013

Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancer.

Andy J Liedtke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.